Acarbose presents in vitro and in vivo antileishmanial activity against Leishmania infantum and is a promising therapeutic candidate against visceral leishmaniasis. (2021)

First Author: Costa RR
Attributed to:  VAccine deveLopment for complex Intracellular neglecteD pAThogEns (VALIDATE) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s00430-021-00707-4

PubMed Identifier: 33870453

Publication URI: http://europepmc.org/abstract/MED/33870453

Type: Journal Article/Review

Volume: 210

Parent Publication: Medical microbiology and immunology

Issue: 2-3

ISSN: 0300-8584